SECOND AMENDMENT TO OFFICE LEASE AGREEMENTOffice Lease Agreement • September 23rd, 2021 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 23rd, 2021 Company IndustryTHIS SECOND AMENDMENT TO OFFICE LEASE AGREEMENT (“Amendment”) dated this 9th day of November, 2017, is by and between ALACHUA FOUNDATION PARK HOLDING COMPANY, LLC, a Florida Limited Liability Company (“Landlord”) and APPLIED GENETIC TECHNOLOGIES CORPORATION, a Delaware corporation (“Tenant”).
AMENDMENT TO OFFICE LEASE AGREEMENTOffice Lease Agreement • September 23rd, 2021 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 23rd, 2021 Company IndustryTHIS AMENDMENT TO OFFICE LEASE AGREEMENT (“Amendment”) dated this 20 day of DECEMBER, 2016, but deemed effective as of October 1, 2016, is by and between ALACHUA FOUNDATION PARK HOLDING COMPANY, LLC, a Florida Limited Liability Company (“Landlord”) and APPLIED GENETIC TECHNOLOGIES CORPORATION, a Delaware corporation (“Tenant”).
FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • September 23rd, 2021 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 23rd, 2021 Company Industry JurisdictionTHIS FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”), dated as of May 13, 2021 (the “First Amendment Effective Date”), is made by and among APPLIED GENETIC TECHNOLOGIES CORPORATION, a Delaware corporation, and each of its Subsidiaries (hereinafter collectively referred to as the “Borrower”), the several banks and other financial institutions or entities from time to time parties to this Agreement (collectively, referred to as the “Lenders”) and HERCULES CAPITAL, INC., a Maryland corporation, in its capacity as administrative agent and collateral agent for itself and the Lenders (in such capacity, the “Agent”).
LEASE [Foundation Park]Lease • September 23rd, 2021 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances) • Florida
Contract Type FiledSeptember 23rd, 2021 Company Industry JurisdictionTHIS LEASE (this “Lease”) is made as of May 13, 2021 (the “Effective Date”) between ALACHUA FOUNDATION PARK HOLDING COMPANY II, LLC, a Florida limited liability company, with its office at 3324 W. University Avenue, PMB #151, Gainesville, Florida 32607 (“Landlord”), and APPLIED GENETIC TECHNOLOGIES CORPORATION, a Delaware corporation, whose address is Suite 101, Building I, 14100 N.W. 113th Terrace, Alachua, Florida 32615 (“Tenant”).
FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (William A. Sullivan)Employment Agreement • September 23rd, 2021 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledSeptember 23rd, 2021 Company Industry JurisdictionTHIS FIRST AMENDMENT AGREEMENT TO EMPLOYMENT AGREEMENT (this “First Amendment”) is entered into as of the 14th day of May 2021 by and between Applied Genetic Technologies Corporation, a Delaware corporation, including its successors and assigns (the “Employer” or “Company”) and William A. Sullivan (“Executive”).
RESTRICTED STOCK UNIT AGREEMENT Granted by Applied Genetic Technologies Corporation Under the 2013 Equity and Incentive PlanRestricted Stock Unit Agreement • September 23rd, 2021 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 23rd, 2021 Company IndustryApplied Genetic Technologies Corporation (the “Company”) hereby grants to the person named below (the “Recipient”) restricted stock units (“Restricted Stock Units”), with each such unit representing the right to receive one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), pursuant to the terms set forth below (the “Award”). The Award is and shall be subject in every respect to the provisions of the Company’s 2013 Equity and Incentive Plan, as amended from time to time (the “Plan”), which is incorporated herein by reference and made a part hereof. The Recipient hereby accepts this Award subject to all the terms and provisions of the Plan and agrees that (a) in the event of any conflict between the terms hereof and those of the Plan, the latter shall prevail, and (b) all decisions under and interpretations of the Plan by the Board or the Committee shall be final, binding and conclusive upon the Recipient and his or her heirs and legal representatives.